These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27966208)

  • 1. Puerarin and zinc additively prevent mandibular bone loss through inhibiting osteoclastogenesis in ovariectomized rats.
    Liu H; Li W; Jia S; Li B
    Histol Histopathol; 2017 Aug; 32(8):851-860. PubMed ID: 27966208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coadministration of puerarin (low dose) and zinc attenuates bone loss and suppresses bone marrow adiposity in ovariectomized rats.
    Liu H; Li W; Ge X; Jia S; Li B
    Life Sci; 2016 Dec; 166():20-26. PubMed ID: 27697446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoprotegerin gene-modified BMSCs with hydroxyapatite scaffold for treating critical-sized mandibular defects in ovariectomized osteoporotic rats.
    Liu X; Bao C; Xu HHK; Pan J; Hu J; Wang P; Luo E
    Acta Biomater; 2016 Sep; 42():378-388. PubMed ID: 27318268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synergistic effects of Sr and Si bioactive ions on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regeneration.
    Mao L; Xia L; Chang J; Liu J; Jiang L; Wu C; Fang B
    Acta Biomater; 2017 Oct; 61():217-232. PubMed ID: 28807800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway.
    Qiu Z; Li L; Huang Y; Shi K; Zhang L; Huang C; Liang J; Zeng Q; Wang J; He X; Qin L; Wang X
    J Orthop Translat; 2022 Mar; 33():55-69. PubMed ID: 35228997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Puerarin enhances bone mass by promoting osteoblastogenesis and slightly lowering bone marrow adiposity in ovariectomized rats.
    Li B; Liu H; Jia S
    Biol Pharm Bull; 2014; 37(12):1919-25. PubMed ID: 25590084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Puerarin Stimulates Osteogenic Differentiation and Bone Formation Through the ERK1/2 and p38-MAPK Signaling Pathways.
    Yang X; Yang Y; Zhou S; Gong X; Dai Q; Zhang P; Jiang L
    Curr Mol Med; 2018 Mar; 17(7):488-496. PubMed ID: 29256352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FoxO1 as the critical target of puerarin to inhibit osteoclastogenesis and bone resorption.
    Feng Y; Tang X
    J Pharm Pharmacol; 2024 Jul; 76(7):813-823. PubMed ID: 38554122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro.
    Yuan SY; Sheng T; Liu LQ; Zhang YL; Liu XM; Ma T; Zheng H; Yan Y; Ishimi Y; Wang XX
    Chin J Nat Med; 2016 Apr; 14(4):265-269. PubMed ID: 27114313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc enhances bone metabolism in ovariectomized rats and exerts anabolic osteoblastic/adipocytic marrow effects ex vivo.
    Li B; Liu H; Jia S
    Biol Trace Elem Res; 2015 Feb; 163(1-2):202-7. PubMed ID: 25431298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syringin prevents bone loss in ovariectomized mice via TRAF6 mediated inhibition of NF-κB and stimulation of PI3K/AKT.
    Liu J; Zhang Z; Guo Q; Dong Y; Zhao Q; Ma X
    Phytomedicine; 2018 Mar; 42():43-50. PubMed ID: 29655696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-osteoporotic activity of puerarin 6"-O-xyloside on ovariectomized mice and its potential mechanism.
    Li H; Chen B; Pang G; Chen J; Xie J; Huang H
    Pharm Biol; 2016; 54(1):111-7. PubMed ID: 25857587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsed electromagnetic field stimulates osteoprotegerin and reduces RANKL expression in ovariectomized rats.
    Zhou J; Chen S; Guo H; Xia L; Liu H; Qin Y; He C
    Rheumatol Int; 2013 May; 33(5):1135-41. PubMed ID: 22948539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alendronate (ALN) combined with osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats.
    Wang Y; Huang P; Tang PF; Chan KM; Li G
    J Orthop Surg Res; 2011 Jul; 6():34. PubMed ID: 21752290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats.
    Wang FS; Wang CJ; Chen YJ; Huang YT; Huang HC; Chang PR; Sun YC; Yang KD
    Endocrinology; 2004 May; 145(5):2148-56. PubMed ID: 14962990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Puerarin decreases bone loss and collagen destruction in rats with ligature-induced periodontitis.
    Yang X; Zhang H; Wang J; Zhang Z; Li C
    J Periodontal Res; 2015 Dec; 50(6):748-57. PubMed ID: 25645818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
    Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH
    Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.